2 year survival milestone for EW-001 patient
Filed with ASX · · 4 pages · English
Earlier from AdAlta
- Quarterly Appendix 4C and Activities Report
- Oktopi AI collaboration for research efficiency
- Second BZDS1901 milestone paid
- Regulatory advisors appointed for BZDS1901
- $2.5m placement
Later from AdAlta
- EW-001 IIT study overall survival update
- Investor presentation
- Preliminary Final Report
- Annual Report to shareholders
- Appendix 4G and Corporate Governance Statement
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta